VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
AMLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AMLXAmylyx Pharmaceuticals, Inc.
$33.88$3.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMLXQuarterly Cash Flow

Amylyx Pharmaceuticals, Inc. (AMLX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Amylyx Pharmaceuticals, Inc. (AMLX) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

AMLX Cash Flow Statement

Quarterly statement

AMLX Cash Flow Statement

Amylyx Pharmaceuticals, Inc. (AMLX) cash flow statement — 7-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations-31.42M-36.88M-27.9M-30.37M-25.25M-39.82M-59.01M-41.57M-66.58M-489K13.55M-5.17M8.61M-5.07M-49.7M-43.08M-46.46M-40.63M-28.24M-20.86M
Operating CF Margin %------8873.38%-9992.79%6508.31%-0.55%12.5%-5.03%8.77%-7.1%-227.08%-12486.38%----
Operating CF Growth %-24.46%7.39%52.71%26.95%62.08%-8043.97%-535.45%-704.22%-873.38%90.36%127.27%88%118.53%87.52%-75.96%-106.46%----
Net Income-43.42M-41.28M-33M-34.39M-41.44M-35.91M-37.55M-72.7M-72.7M-118.79M4.73M20.89M22.07M1.57M-42.7M-53.76M-54.07M-47.85M-28.34M-23.14M
Depreciation & Amortization43K98K108K120K141K156K160K221K208K315K301K302K281K204K182K165K105K35K22K10K
Stock-Based Compensation8.32M6.12M6.39M7.08M7.35M6.83M6.74M6.8M9.57M9.92M9.53M10.18M9.95M7.5M6.09M5.52M5.71M4.39M1.09M802K
Deferred Taxes00000000000000000000
Other Non-Cash Items818K3.44M-1.49M-1.24M-1.26M-1.7M-1.66M34.71M5.04M107.9M-2.57M-2.48M-1.98M-2.9M-1.86M-89K-109K2K98K23K
Working Capital Changes2.82M-5.26M92K-1.94M9.96M-9.2M-26.7M-10.6M-8.7M164K1.56M-34.06M-21.71M-11.45M-11.41M5.08M1.9M2.79M-1.11M1.44M
Change in Receivables0050K-85K205K213K980K2.24M16.56M19.7M-11.07M4.85M-16.53M-2M-15.17M-185K-12K-1K02K
Change in Inventory000000000-9.25M-26.48M-14.01M-19.33M-13.3M-9.21M-563K0000
Change in Payables2M10K275K-33K-1.53M1.87M1.47M-3.49M-16.43M-652K15.82M-18.39M13.84M4.61M-800K-1.1M-1.26M5.02M1.39M156K
Cash from Investing-149.8M36.26M29.47M5.24M22.99M-43.66M64.98M38.82M-28.96M819K20.93M-108.09M123.22M55.99M-228.18M84.04M4.46M-99.31M2.81M-49.21M
Capital Expenditures-30K-4M-86K-24K-17K-11K-20K19K-89K-67K-356K-357K-278K-250K-620K-459K-1.1M-342K-186K-153K
CapEx % of Revenue-------3.01%4.57%-8.7%0.08%0.33%0.35%0.28%0.35%2.83%133.04%----
Acquisitions00000000000000227.56M00000
Investments--------------------
Other Investing0000000-36.2M000000-227.56M0003M0
Cash from Financing1.48M3.22M-208K191.61M-31K65.66M110K80K27K131K230K889K1.38M1.04M232.16M0-828K200.46M-1.06M131.65M
Debt Issued (Net)000191.11M00000000000000-263K263K
Equity Issued (Net)1.97M7.16M256.69M2.66M72K970K148K491K47K1.45M347K984K03.4M231.55M0-828K200.9M209K132.72M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-494K-3.94M-256.9M-2.16M-103K64.69M110K80K27K-1.31M-117K-95K1.38M-2.36M612K00-442K-1.01M-1.33M
Net Change in Cash-179.81M2.48M1.48M167.09M-1.68M-17.62M5.56M-2.44M-95.55M351K34.94M-112.5M133.2M52.04M-45.21M40.59M-42.96M60.44M-26.49M61.58M
Free Cash Flow-31.45M-36.88M-27.99M-30.39M-25.27M-39.84M-59.03M-41.55M-66.67M-556K13.2M-5.53M8.33M-5.32M-50.32M-43.54M-47.57M-40.98M-28.43M-21.02M
FCF Margin %------8876.39%-9988.22%6517.01%-0.63%12.17%-5.38%8.48%-7.45%-229.92%-12619.42%----
FCF Growth %-24.5%7.41%52.58%26.86%62.1%-7064.57%-547.35%-651.92%-900.25%89.55%126.22%87.31%117.51%87.01%-76.99%-107.14%----
FCF per Share-0.28-0.33-0.30-0.33-0.28-0.46-0.86-0.61-0.98-0.010.19-0.080.12-0.08-0.77-0.74-0.82-0.79-0.51-0.38
FCF Conversion (FCF/Net Income)0.72x0.89x0.85x0.88x0.61x1.11x1.57x0.57x0.92x0.00x2.86x-0.25x0.39x-3.22x1.16x0.80x0.86x0.85x1.00x0.90x
Interest Paid00000000000000000000
Taxes Paid000000444K-17K6K0002.56M0027K0000